CIK 0001680367
- Non-accelerated filer
- Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812575858
- Phone
- +1 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | Redmile Group, LLC Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Lee Michael Stewart Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Brous Tyler Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Brownstein Carrie Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Boudreau Helen M Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Gibson Neil W Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-06-08 | Golumbeski George Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2022-04-26 | Golumbeski George Director | Purchase | +28,330 | $3.63 | $103K | 54,613 |
| 2022-04-22 | Golumbeski George Director | Purchase | +234 | $3.67 | $859 | 26,283 |
| 2022-04-21 | Golumbeski George Director | Purchase | +26,049 | $3.69 | $96K | 26,049 |
| 2022-01-28 | Schreiber Taylor Chief Executive Officer | Option exercise | +3,926 | $4.67 | $18K | 17,052 |
| 2022-01-28 | Schreiber Taylor Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −3,926 | 176,597 | ||
| 2022-01-19 | Brous Tyler Director | Purchase | +3,000 | $6.87 | $21K | 229,672 |
| 2022-01-18 | Brous Tyler Director | Purchase | +2,500 | $7.01 | $18K | 226,672 |
| 2022-01-14 | Brous Tyler Director | Purchase | +2,500 | $7.16 | $18K | 224,172 |
| 2022-01-12 | Thomson Erin Ator General Counsel | Option exercise | +10,000 | $2.95 | $30K | 79,084 |
| 2022-01-12 | Thomson Erin Ator General Counsel | Option exercise · Stock Option (Right to Buy) | −10,000 | 53,705 | ||
| 2022-01-10 | DeYoung Casi Chief Business Officer | Grant or award | +21,363 | 21,363 | ||
| 2022-01-10 | DeYoung Casi Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +42,725 | 42,725 | ||
| 2022-01-10 | Pandite Arundathy N. Chief Medical Officer | Grant or award | +34,738 | 140,904 |
Page 10 of 18 · 360 trades